证券之星消息，截至2025年8月18日收盘，五洲医疗(301234)报收于40.52元，上涨0.47%，换手率 4.84%，成交量3.29万手，成交额1.33亿元。 8月18日的资金流向数据方面，主力资金净流出397.44万元，占总成交额2.98%，游资资金净流入539.74 万元，占总成交额4.05%，散户资金净流出142.3万元，占总成交额1.07%。 近5日资金流向一览见下表： 五洲医疗2025年一季报显示，公司主营收入1.04亿元，同比上升15.59%；归母净利润563.45万元，同比 下降43.0%；扣非净利润456.28万元，同比下降44.82%；负债率10.75%，投资收益195.71万元，财务费 用-114.97万元，毛利率14.62%。五洲医疗（301234）主营业务：一次性使用无菌输注类医疗器械的研 发、生产、销售以及其他诊断、护理等相关医疗用品的集成供应,主要通过"ODM+集成供应"的模式满 足国外医疗器械品牌商对医疗用品的一站式采购需求。 资金流向名词解释：指通过价格变化反推资金流向。股价处于上升状态时主动性买单形成的成交额是推 动股价上涨的力量，这部分成交额被定义为资金流入，股价处于 ...

8月15日，五洲医疗今日收盘40.33元，下跌1.99%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到76.78倍，总市值27.42亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均56.58倍，行业中值39.97倍，五洲医疗排 名第97位。 资金流向方面，8月15日，五洲医疗主力资金净流出112.57万元，近5日总体呈流入状态，5日共流入 366.58万元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13五洲医疗76.7868.613.5727.42亿行业平均 56.5852.305.00119.53亿行业中值39.9739.072.9157.03亿1九安医疗11.3611.490.89191.70亿2英科医疗 15.6416.861.39247.04亿3山东药玻16.2816.331.87154.02亿4新华医疗16.6315.411.36106.59亿5奥美医疗 17.1216.781.7661.87亿6振德医疗17.3816.381.1163.10亿7九强生物17.7016.462.1787.65亿8康德莱 18.0418.051.4938.87亿9维力医疗18 ...

Core Viewpoint - Wuzhou Medical's stock closed at 43.85 yuan, up 3.03%, with a rolling PE ratio of 83.48, marking a new low in 481 days, and a total market value of 2.982 billion yuan [1] Group 1: Company Overview - Wuzhou Medical specializes in the research, manufacturing, and sales of disposable sterile infusion medical devices and other related medical supplies [1] - The main products include syringes, safety syringes, insulin syringes, infusion devices, blood transfusion devices, and various types of needles [1] Group 2: Financial Performance - For Q1 2025, Wuzhou Medical reported revenue of 104 million yuan, a year-on-year increase of 15.59%, while net profit was 5.6345 million yuan, reflecting a year-on-year decrease of 43.00% [1] - The gross profit margin for sales was 14.62% [1] Group 3: Shareholder Information - As of July 31, 2025, Wuzhou Medical had 7,255 shareholders, an increase of 848 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 4: Industry Comparison - The average PE ratio for the medical device industry is 57.51, with a median of 41.25, placing Wuzhou Medical at 101st in the industry ranking [1][2] - The industry average market value is 120.28 billion yuan, while Wuzhou Medical's market value is significantly lower at 2.982 billion yuan [2]

8月11日，五洲医疗今日收盘42.56元，上涨1.19%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到81.02倍，创480天以来新低，总市值28.94亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均56.56倍，行业中值39.76倍，五洲医疗排 名第101位。 股东方面，截至2025年7月31日，五洲医疗股东户数7255户，较上次增加848户，户均持股市值35.28万 元，户均持股数量2.76万股。 安徽宏宇五洲医疗器械股份有限公司的主营业务是一次性使用无菌输注类医疗器械的研发、制造和销 售，以及其他诊断、护理等相关医疗用品的集成供应。公司的主要产品是注射器、安全型注射器、胰岛 素注射器、配药注射器、输液器、输血器、注射针、静脉输液针、采血针、胰岛素注射笔用针头、安全 注射针、安全采血针、血压表、面罩。 最新一期业绩显示，2025年一季报，公司实现营业收入1.04亿元，同比15.59%；净利润563.45万元，同 比-43.00%，销售毛利率14.62%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13五洲医疗81.0272.413.7728.94亿行业平均 56. ...

Company Overview - Wuzhou Medical's stock price closed at 42.06 yuan on August 8, 2025, down 0.78% from the previous trading day [1] - The opening price was 42.21 yuan, with a daily high of 43.24 yuan and a low of 41.61 yuan, resulting in a trading range of 3.85% [1] - The trading volume was 21,121 hands, with a transaction amount of 0.89 billion yuan and a turnover rate of 3.11% [1] Business Operations - Wuzhou Medical specializes in the research, development, production, and sales of medical devices, including medical consumables and equipment [1] - The company operates within the medical device industry and is also involved in related concepts such as medical aesthetics [1] Market Activity - On the morning of August 8, Wuzhou Medical experienced a rapid decline, with a drop of over 2% within 5 minutes [1] - By the end of the trading day, the net inflow of main funds was 2.773 million yuan, accounting for 0.1% of the circulating market value [1] - Over the past five trading days, the cumulative net outflow of main funds was 1.8575 million yuan [1]

Group 1 - The stock price of Wuzhou Medical is reported at 40.80 yuan as of August 6, 2025, with a decrease of 1.30 yuan, representing a decline of 3.09% from the previous trading day [1] - The stock reached a low of 40.24 yuan and a high of 42.23 yuan during the trading session, with a volatility of 4.73% [1] - A quick rebound was observed at 10:48 AM, where the stock price increased by over 2% within 5 minutes, recovering to 41.58 yuan [1] Group 2 - Wuzhou Medical specializes in the research and production of medical devices, including products in the medical beauty consumables sector [1] - The company is registered in Anhui Province and holds the qualification of a specialized and innovative enterprise [1] - The current total market capitalization is 2.774 billion yuan, with the circulating market value equal to the total market value [1] Group 3 - On August 6, the net outflow of main funds was 97,700 yuan, with a cumulative net outflow of 16.2434 million yuan over the past five trading days [1] - The trading volume for the day was 45,039 hands, with a transaction amount of 185 million yuan, resulting in a turnover rate of 6.62% [1]

Core Viewpoint - Wuzhou Medical's stock closed at 42.18 yuan on August 4, marking a 3.64% increase, with a rolling PE ratio of 80.30, the lowest in 475 days, and a total market value of 2.868 billion yuan [1] Group 1: Company Performance - In the latest quarterly report for Q1 2025, Wuzhou Medical achieved operating revenue of 104 million yuan, a year-on-year increase of 15.59%, while net profit was 5.6345 million yuan, reflecting a year-on-year decrease of 43.00%, with a gross profit margin of 14.62% [1] - The main business of Anhui Hongyu Wuzhou Medical Device Co., Ltd. includes the research, manufacturing, and sales of disposable sterile infusion medical devices, along with other diagnostic and nursing-related medical supplies [1] Group 2: Industry Comparison - The average PE ratio for the medical device industry is 54.32, with a median of 38.11, positioning Wuzhou Medical at the 100th rank within the industry [1] - The PE ratio for Wuzhou Medical is significantly higher than the industry average and median, indicating a potential overvaluation compared to peers [2]

五洲医疗最新股价报42.18元，较前一交易日上涨1.48元。盘中最高触及43.06元，最低下探39.60元，成 交量为45001手，成交金额达1.87亿元。 该公司主营业务为医疗器械的研发、生产和销售，产品涵盖医疗美容等多个领域。根据最新披露数据， 五洲医疗股东户数较上期增加848户，增幅达13.24%，最新股东户数为7255户。公司最新总股本为6800 万股，均为流通股。 数据显示，五洲医疗当日主力资金净流出573.21万元，近五日主力资金净流出1822.86万元。 风险提示：股市有风险，投资需谨慎。 来源:金融界 ...

Group 1 - The core point of the article indicates that Wuzhou Medical has seen an increase in the number of shareholders, with a total of 7,255 shareholders as of July 31, 2025, representing a growth of 848 shareholders or 13.24% compared to the previous period [1] - The average number of shares held per shareholder decreased from 10,600 shares to 9,400 shares, while the average market value of shares held increased from 317,400 yuan to 377,000 yuan [1] - During the same period, Wuzhou Medical's stock price rose by 13.27% [1] Group 2 - As of the latest report, Wuzhou Medical's stock price is 42.18 yuan, reflecting an increase of 3.64%, with a market capitalization of 2.868 billion yuan [1] - The changes in the number of shareholders and their holdings over the last five reporting dates are detailed, showing a trend of increasing shareholder numbers and fluctuating average holdings [1]

Core Viewpoint - Wuzhou Medical's stock closed at 40.7 yuan on August 1, with a PE ratio of 77.48, marking a 473-day low, and a total market value of 2.768 billion yuan [1] Company Summary - Wuzhou Medical specializes in the research, manufacturing, and sales of disposable sterile infusion medical devices, along with other diagnostic and nursing supplies [1] - The company's main products include syringes, safety syringes, insulin syringes, infusion sets, blood transfusion sets, and various types of needles [1] - For Q1 2025, Wuzhou Medical reported revenue of 104 million yuan, a year-on-year increase of 15.59%, and a net profit of 5.6345 million yuan, reflecting a year-on-year decrease of 43.00% with a gross margin of 14.62% [1] Industry Summary - The average PE ratio for the medical device industry is 53.65, with a median of 37.22, placing Wuzhou Medical at the 97th position in the industry ranking [1] - The industry average market value is 11.474 billion yuan, while the median is 5.530 billion yuan [2] - Other companies in the industry have significantly lower PE ratios, with the lowest being 11.01 for Jiuan Medical and the highest being 20.06 for Antu Biology [2]